Quantzig Presents a Holistic Portfolio of Business Continuity Solutions for Pharma and Life Sciences Companies

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200504005421/en/

Ensuring business continuity is crucial for the success of any enterprise, especially for those operating in the pharma and life sciences industries, where criticality and compliance with FDA regulations may be impacted by a host of factors ranging from cybercrime to natural disasters to supply chain disruptions. In such a scenario, pharma and life sciences companies often find themselves stranded with no clear action plans and business continuity solutions in place. To grow and compete, pharma and life sciences companies are now leveraging analytics backed solutions to future proof of their success and drive better results.

Effective use of advanced analytics capabilities will enable pharma and life sciences companies to sustain a leading edge. Request a FREE proposal to learn more.

To succeed amid the COVID-19 crisis, businesses must devise new strategies, embrace partnerships, and adopt technology to discover, optimize, and demonstrate value. The industry-wide shift to value-based business models and the move towards more personalized healthcare services have helped fuel interest in using data to understand and demonstrate the value of pharmaceutical and medical device innovations. At Quantzig, we understand the importance of such factors from a business perspective, which is why we’ve developed a complex suite of analytics powered business support solutions to address all your challenges and focus on core business activities.

Leveraging data is not new for pharma and life sciences companies, but today the stakes are higher, and the competition is intense. Schedule a FREE demo to gain limited-time complimentary access to our advanced analytics platforms.

Our COVID-19 business continuity solutions empower pharma and life sciences companies to continue operations by following a three-step approach:

• Business Impact Analysis: Gauge the impact of a crisis on existing business functions

• Business Gap Analysis: Helps identify the discrepancies between the necessary resources and the organization’s current capabilities

• Develop Action Plans and Recovery Strategies: This step includes bring together a recovery team, documenting the action plans and setting protocols for relocation and manual workarounds

According to an advanced analytics expert at Quantzig, “The COVID-19 crisis has paved way for a host of new challenges in the pharma and life sciences industry, which can only be addressed by devising advanced action plans backed by analytical methodologies and data-driven approaches.”

Speak to an analytics expert to learn how analytics can help devise effective strategies to improve decision-making and design initiatives to promote superior services

COVID-19 Resource Library: Learn how Quantzig can help you navigate the crisis (https://bit.ly/3df3eJW).

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

View source version on businesswire.com: https://www.businesswire.com/news/home/20200504005421/en/